PubMed

Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.

Schumock GT, Andress DL, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K.

Nephron Clin Pract. 2009;113(1):c54-61. Epub 2009 Jul 10.PMID: 19590235 [PubMed - indexed for MEDLINE]Related articles

Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.

Joyce AT, Smith P, Khandker R, Melin JM, Singh A.

J Rheumatol. 2009 Apr;36(4):743-52. Epub 2009 Feb 17.PMID: 19228658 [PubMed - indexed for MEDLINE]Related articles

Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.

Schumock GT, Andress D, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K.

Curr Med Res Opin. 2008 Sep 29. [Epub ahead of print]PMID: 18826748 [PubMed - as supplied by publisher]Related articles

A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease.

Foody JM, Joyce AT, Jeffers BW, Liu LZ, Benner JS.

Diabetes Res Clin Pract. 2008 Oct;82(1):e13-5. Epub 2008 Sep 6.PMID: 18774618 [PubMed - indexed for MEDLINE]Related articles

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.

Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.

Curr Med Res Opin. 2008 Jul;24(7):1987-2000. Epub 2008 Jun 4.PMID: 18554430 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.

Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.

Clin Ther. 2008 Jan;30(1):195-205.PMID: 18343257 [PubMed - indexed for MEDLINE]Related articles

Burden of illness among commercially insured patients with Alzheimer's disease.

Joyce AT, Zhao Y, Bowman L, Flynn JA, Carter CT, Ollendorf DA.

Alzheimers Dement. 2007 Jul;3(3):204-10.PMID: 19595939 [PubMed - in process]Related articles

Effect of initial ziprasidone dose on length of therapy in schizophrenia.

Joyce AT, Harrison DJ, Loebel AD, Carter CT, Ollendorf DA.

Schizophr Res. 2006 Apr;83(2-3):285-92. Epub 2006 Mar 20.PMID: 16545543 [PubMed - indexed for MEDLINE]Related articles

Impact of atypical antipsychotics on outcomes of care in schizophrenia.

Joyce AT, Harrison DJ, Loebel AD, Ollendorf DA.

Am J Manag Care. 2005 Sep;11(8 Suppl):S254-61.PMID: 16180964 [PubMed - indexed for MEDLINE]Related articlesFree article

End-stage renal disease-associated managed care costs among patients with and without diabetes.

Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D, Pedan A, Ollendorf DA, Alexander CM.

Diabetes Care. 2004 Dec;27(12):2829-35.PMID: 15562193 [PubMed - indexed for MEDLINE]Related articlesFree article

Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.

Ollendorf DA, Joyce AT, Rucker M.

MedGenMed. 2004 Jan 20;6(1):5.PMID: 15208518 [PubMed - indexed for MEDLINE]Related articlesFree article